amoxicillin has been researched along with Pulmonary Disease, Chronic Obstructive in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Blakey, JD; Bonnett, LJ; Stolbrink, M | 1 |
| Moore, D | 1 |
| Andersen, CØ; Bagge, K; Eklöf, J; Hansen, EF; Hertz, FB; Jarløv, JO; Jensen, JS; Sivapalan, P | 1 |
| Lange, P; Nielsen, SK | 1 |
| Buehrle, DJ; Clancy, CJ; Decker, BK; Shively, NR | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Kloesel, B; Park, MA; Sartori-Valinotti, JC | 1 |
| Bathoorn, E; Friedrich, AW; Groenhof, F; Hendrix, R; Kerstjens, HA; Kocks, JW; Sinha, B; van der Molen, T | 1 |
| Alvarez, C; Bayona, C; Cots, JM; González, I; Hernández, S; Llor, C; Miravitlles, M; Ribas, A | 1 |
| Domínguez-Pérez, Á; Iribarren-Marín, Mdel A; Martín-García, C; Pérez-Vega, H | 1 |
| Brusse-Keizer, M; Hendrix, R; Kerstjens, H; Movig, K; ten Bokum, L; van der Palen, J; van der Valk, P | 1 |
| Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K | 2 |
| Shmelev, EI | 1 |
| Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J | 1 |
| Dimopoulos, G; Falagas, ME; Korbila, IP; Manta, K; Siempos, II | 1 |
| Barcelona, L; Marín, M; Stamboulian, D | 1 |
5 review(s) available for amoxicillin and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Not all exacerbations of chronic obstructive pulmonary disease should be treated with antibiotics].
Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; C-Reactive Protein; Calcitonin; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Sputum | 2017 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors | 2004 |
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Clavulanic Acid; Clinical Trials as Topic; Humans; Macrolides; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome | 2007 |
[Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sulbactam | 2008 |
3 trial(s) available for amoxicillin and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.
Topics: Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Primary Health Care; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Spain; Spirometry; Treatment Outcome | 2009 |
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Drug Therapy, Combination; Epidemiologic Methods; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Oxygen Inhalation Therapy; Prognosis; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2005 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2007 |
10 other study(ies) available for amoxicillin and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Antibiotics for COPD exacerbations: does drug or duration matter? A primary care database analysis.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Disease Progression; Doxycycline; Female; Humans; Male; Middle Aged; Primary Health Care; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Time Factors | 2019 |
Management of COPD exacerbations: pharmacotherapeutics of medications.
Topics: Albuterol; Amoxicillin; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive | 2020 |
Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cohort Studies; Data Analysis; Denmark; Disease Progression; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Treatment Outcome | 2021 |
Prevalence of Inappropriate Antibiotic Prescribing in Primary Care Clinics within a Veterans Affairs Health Care System.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Delivery of Health Care; Doxycycline; Female; Fluoroquinolones; Humans; Inappropriate Prescribing; Male; Middle Aged; Physicians, Primary Care; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Retrospective Studies; Soft Tissue Infections; Trimethoprim, Sulfamethoxazole Drug Combination; United States; United States Department of Veterans Affairs; Urinary Tract Infections | 2018 |
76-year-old woman with pruritus [corrected] and lip swelling.
Topics: Aged; Amoxicillin; Anaphylaxis; Anti-Allergic Agents; Anti-Bacterial Agents; Antibiotic Prophylaxis; Disease Management; Drug Substitution; Emergency Treatment; Epinephrine; Female; Humans; Immunoglobulin E; Microbial Sensitivity Tests; Otitis Media; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Skin Tests; Treatment Outcome | 2013 |
Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Bronchodilator Agents; Clinical Decision-Making; Disease Progression; Doxycycline; Drug Prescriptions; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Lung; Male; Middle Aged; Netherlands; Practice Guidelines as Topic; Practice Patterns, Physicians'; Predictive Value of Tests; Primary Health Care; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Severity of Illness Index; Sputum; Time Factors; Treatment Outcome | 2017 |
[Spondylodiscitis caused by Streptococcus pneumonia associated with an infected abdominal aortic aneurysm].
Topics: Alcoholism; Amoxicillin; Aneurysm, Infected; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aortic Aneurysm, Abdominal; Aortitis; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Discitis; Disease Susceptibility; Humans; Lumbar Vertebrae; Male; Middle Aged; Naproxen; Pneumococcal Infections; Psoas Abscess; Pulmonary Disease, Chronic Obstructive; Rifampin; Tomography, X-Ray Computed | 2011 |
Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Disease Progression; Female; Humans; Length of Stay; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum | 2011 |
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Child; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Randomized Controlled Trials as Topic; Time Factors | 2004 |
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2004 |